Well Referenced

Tag: ApoB

Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers

This post hoc analysis of the DURATION-1 trial evaluated the effects of exenatide administered once weekly (ExQW) or twice daily (ExBID) over 30 weeks on cardiovascular risk markers in 211 patients with type 2 diabetes. Both regimens led to significant reductions in triglycerides, very low-density lipoprotein cholesterol (VLDL-C), and high-sensitivity

Read More »
June 26, 2025 No Comments

Obesity, dyslipidemia, and high blood pressure are associated with cardiovascular risk, determined using high-sensitivity C-reactive protein concentration, in young adults

This 2020 observational study published in the Journal of International Medical Research (PMID: 33342336) analyzed 300 young adults in southern Mexico to examine the relationship between high-sensitivity C-reactive protein (hs-CRP) and cardiometabolic risk factors. It found that elevated hs-CRP (>28.57 nmol/L) was strongly associated with obesity (OR = 13.9), high

Read More »
June 26, 2025 No Comments